Perspective · 3 Nov 2025
Short communicationPublished 6 Dec 2022
Prostate Cancer Recognition: Using the Random Forest Technique and Other Ml Techniques
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The exact etiology of prostate cancer is unknown. Prostate cells alter their DNA, which is how doctors know prostate cancer starts. The instructions that inform a cell what to do are encoded in its DNA. The adjustments instruct the cells to multiply and develop faster than usual. In the U.S., 98% of men with prostate cancer survive five years after diagnosis. The survival rate after ten years is similarly 98%. Prostate cancer is only detected in the prostate and adjacent organs in around 84% of cases. The local or regional level is what is being discussed here. Many men may pass away from other illnesses before prostate cancer becomes a serious concern because of its sluggish growth. However, many prostate cancers are more dangerous and may extend beyond the prostate gland because they are more aggressive. They were considering the importance of prostate cancer, in this article, using machine learning algorithms and features of sampled prostate tissues, 100 men, healthy and sick people were classified.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Chemotherapy: Open Access.
Opinion · 3 Nov 2025
Evaluation of Surgical Radiotherapy and Chemotherapy in the Treatment of Gynaecological Malignancies
Research article · 18 Aug 2025
Response Evaluation to Oxaliplatin-Based Adjuvant Chemotherapy after Curative Resection between Right and Left-Sided Stage II and III Colon Cancer: A Retrospective Survival Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalChemotherapy: Open Access
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Seyed Matin Malakouti”

